Filing Details
- Accession Number:
- 0001209191-23-021136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-24 19:18:57
- Reporting Period:
- 2023-03-24
- Accepted Time:
- 2023-03-24 19:18:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582313 | Xenon Pharmaceuticals Inc. | XENE | Pharmaceutical Preparations (2834) | 980661854 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1880129 | John Christopher Kenney | 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-03-24 | 700 | $35.01 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
